Candriam SCA’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.5M | Sell |
|
|||||
|
2025
Q1 | $25.6M | Sell |
|
|||||
|
2024
Q4 | $30.9M | Sell |
|
|||||
|
2024
Q3 | $41.2M | Sell |
|
|||||
|
2024
Q2 | $61.8M | Sell |
|
|||||
|
2024
Q1 | $57.6M | Buy |
|
|||||
|
2023
Q4 | $47.9M | Sell |
|
|||||
|
2023
Q3 | $60.1M | Buy |
|
|||||
|
2023
Q2 | $66.6M | Sell |
|
|||||
|
2023
Q1 | $76.5M | Buy |
|
|||||
|
2022
Q4 | $82.5M | Buy |
|
|||||
|
2022
Q3 | $67.1M | Sell |
|
|||||
|
2022
Q2 | $51.4M | Buy |
|
|||||
|
2022
Q1 | $51.2M | Buy |
|
|||||
|
2021
Q4 | $52.3M | Sell |
|
|||||
|
2021
Q3 | $77.2M | Sell |
|
|||||
|
2021
Q2 | $95.2M | Sell |
|
|||||
|
2021
Q1 | $91.9M | Hold |
|
|||||
|
2020
Q4 | $95.7M | Buy |
|
|||||
|
2020
Q3 | $104M | Buy |
|
|||||
|
2020
Q2 | $91.2M | Sell |
|
|||||
|
2020
Q1 | $114M | Hold |
|
|||||
|
2019
Q4 | $117M | Sell |
|
|||||
|
2019
Q3 | $102M | Sell |
|
|||||
|
2019
Q2 | $145M | Sell |
|
|||||
|
2019
Q1 | $155M | Buy |
|
|||||
|
2018
Q4 | $171M | Buy |
|
|||||
|
2018
Q3 | $179M | Buy |
|
|||||
|
2018
Q2 | $87.8M | Buy |
|
|||||
|
2018
Q1 | $56.2M | Buy |
|
|||||
|
2017
Q4 | $14.1M | Sell |
|
|||||
|
2017
Q3 | $88.4M | Buy |
|
|||||
|
2017
Q2 | $59.6M | Buy |
|
|||||
|
2017
Q1 | $47.8M | Sell |
|
|||||
|
2016
Q4 | $51.8M | Sell |
|
|||||
|
2016
Q3 | $58.1M | Buy |
|
|||||
|
2016
Q2 | $40.1M | Sell |
|
|||||
|
2016
Q1 | $47M | Sell |
|
|||||
|
2015
Q4 | $74.4M | Buy |
|
|||||
|
2015
Q3 | $62.1M | Buy |
|
|||||
|
2015
Q2 | $82.1M | Buy |
|
|||||
|
2015
Q1 | $79.9M | Buy |
|
|||||
|
2014
Q4 | $63.8M | Buy |
|